RXST Stock Summary and Trading Ideas (Rxsight | NASDAQ:RXST)

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

Rxsight trades on the NASDAQ stock market under the symbol RXST.

As of September 11, 2026, RXST stock price climbed to $6.02 with 416,790 million shares trading.

RXST has a beta of 1.02, meaning it tends to be more sensitive to market movements. RXST has a correlation of 0.04 to the broad based SPY ETF.

RXST has a market cap of $250.39 million. This is considered a Small Cap stock.

Last quarter Rxsight reported $34 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.12.

In the last 3 years, RXST traded as high as $66.54 and as low as $4.48.

The top ETF exchange traded funds that RXST belongs to (by Net Assets): VTI, VXF, VTWO, SCHA, VHT.

RXST has underperformed the market in the last year with a price return of -36.1% while the SPY ETF gained +17.4%. However, in the short term, RXST had mixed performance relative to the market. It has outperformed in the last 3 months, returning +25.4% vs +3.9% return in SPY. But in the last 2 weeks, RXST shares have been beat by the market, returning -14.6% compared to an SPY return of -0.7%.

RXST support price is $5.71 and resistance is $6.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RXST shares will trade within this expected range on the day.